Good behaviour bond given to NDIS worker for fraudulent claims to keep provider afloat
An Adelaide man has avoided jail for making a series of fraudulent claims with the NDIS in a bid to help the struggling business he was working for survive.

An Adelaide man has avoided jail for making a series of fraudulent claims with the NDIS in a bid to help the struggling business he was working for survive.

Queensland hosts New South Wales in a winner-takes-all Game III of the State of Origin series at Lang Park. The Maroons aim to leverage their historical advantage at home against the Blues, who have a mixed record in Brisbane deciders.

Hodan Abby, the last known Australian woman linked to the Islamic State in Syria, is expected to return to Australia under strict conditions. This comes amid allegations she enslaved, beat, and raped a Yazidi girl in her Syrian home a decade ago. The victim, known as Sara, identified Abby (under the nom de guerre 'Umm Osama') as her abuser.

Nigel Farage, leader of Reform UK, announced he will resign as an MP and trigger a by-election in his Clacton constituency. The move comes amid scrutiny of his finances and donations, including a £5 million crypto gift. Major parties will not contest the by-election, calling it a 'circus' or 'fake'.

Ayatollah Ali Khamenei's funeral in Tehran revealed the image Iran wishes to project, highlighting his sons Mostafa, Meysam, and Masoud, while noting the absence of Supreme Leader Mojtaba Khamenei due to rumored health issues. Analysts suggest the event aims to project defiance and stability amid the US-Israel war.

Marine Le Pen announced her candidacy for the 2027 French presidential election after an appeals court reduced her ban on holding public office. The court upheld her conviction for misusing EU funds but shortened her ban, allowing her to run.

A dispute over Australia's Pharmaceutical Benefits Scheme (PBS) pricing could force 10,000 people with multiple sclerosis (MS) to pay up to $33,000 annually for vital treatments like Ocrevus and Kesimpta, as drugmakers reject a 50% price cut.